Yahoo Web Search

Search results

    • Small Business - Picayune Item | Picayune Item

      The Picayune Item· 2 days ago

      CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC PR Newswire SUZHOU, China, June 1, 2024 EMA CHMP recommendation is based on the results of a Phase 3 clinical